Skip to main content
Top
Published in: Clinical Rheumatology 2/2005

01-04-2005 | Original Article

Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus

Authors: Ou Jin, Ling-yun Sun, Kang-xin Zhou, Xin-su Zhang, Xue-bing Feng, Mo-yin Mok, Chak-sing Lau

Published in: Clinical Rheumatology | Issue 2/2005

Login to get access

Abstract

Increased lymphocyte apoptosis and defects in macrophage removal of apoptotic cells have been suggested to contribute to the development of systemic lupus erythematosus (SLE). The aim of this study was to investigate the relationship between peripheral lymphocyte apoptosis, macrophage function as determined by the serum levels of neopterin and interferon-γ (IFN-γ), and SLE disease activity. Peripheral apoptotic lymphocytes (AL) were detected by annexin V-fluorescein isothiocyanate (FITC) staining and flow cytometry. Serum levels of neopterin and IFN-γ were measured by enzyme-linked immunosorbent assay (ELISA). SLE disease activity was determined using the systemic lupus activity measure (SLAM) and the serum titer of anti-dsDNA antibodies. The percentage of AL in the peripheral blood of active SLE patients was significantly higher (13.07±7.39%, n=30) than that of the inactive SLE patients (4.08±3.55%, n=8, p<0.01) and normal controls (5.13±3.37%, n=11, p<0.01). Serum levels of neopterin in active SLE patients were significantly higher (1.39±1.10 μg/dl, n=22) than in controls (0.26±0.19 μg/dl, n=20, p<0.01). Serum levels of IFN-γ in active SLE patients were elevated (58.97±34.52 ng/l, n=15) when compared with controls (28.06±2.35 ng/l, n=16, p<0.05). The percentage of AL correlated significantly with serum levels of neopterin (r=0.446, p<0.05, n=22) and SLAM score (r=0.533, p<0.001, n=38), but not with the serum levels of IFN-γ. The SLAM score also correlated with the serum levels of neopterin (r=0.485, p<0.05, n=22), but not with those of IFN-γ. Our study supported the hypothesis that increased lymphocyte apoptosis has a pathogenic role in SLE. The increased levels of serum neopterin may suggest an attempt of the patients’ macrophage system to remove the apoptotic cell excess. Since serum levels of neopterin correlated with the overall lupus disease activity, they may be regarded as an index of SLE disease activity.
Literature
1.
go back to reference Emlen W, Niebur J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685–3693PubMed Emlen W, Niebur J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685–3693PubMed
2.
go back to reference Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M (1998) High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 7:113–118CrossRefPubMed Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M (1998) High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 7:113–118CrossRefPubMed
3.
go back to reference Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMed Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMed
4.
go back to reference Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250CrossRefPubMed Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250CrossRefPubMed
5.
go back to reference Baumann I, Kolowos W, Voll RE, et al. (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191–201CrossRefPubMed Baumann I, Kolowos W, Voll RE, et al. (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191–201CrossRefPubMed
6.
go back to reference Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449CrossRefPubMed Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449CrossRefPubMed
7.
go back to reference Taylor PR, Carugati A, Fadok VA, et al. (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 192:359–366CrossRefPubMed Taylor PR, Carugati A, Fadok VA, et al. (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 192:359–366CrossRefPubMed
8.
go back to reference Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897CrossRefPubMed Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897CrossRefPubMed
9.
go back to reference Huber C, Batchelor JR, Fuchs D, et al. (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316CrossRefPubMed Huber C, Batchelor JR, Fuchs D, et al. (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316CrossRefPubMed
10.
go back to reference Berdowska A, Zwirska-Korczala K (2001) Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 26:319–329CrossRefPubMed Berdowska A, Zwirska-Korczala K (2001) Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 26:319–329CrossRefPubMed
11.
go back to reference Le Page C, Genin P, Baines MG, Hiscott J. Hiscott J (2000) Interferon activation and innate immunity. Rev Immunogenet 2:374–386PubMed Le Page C, Genin P, Baines MG, Hiscott J. Hiscott J (2000) Interferon activation and innate immunity. Rev Immunogenet 2:374–386PubMed
12.
go back to reference Liang MH, Socher SA, Larson MG, Schur PH (1989) Reliability and validity of six systems for the clinical assessment of six systems of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107–1118PubMed Liang MH, Socher SA, Larson MG, Schur PH (1989) Reliability and validity of six systems for the clinical assessment of six systems of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107–1118PubMed
13.
go back to reference Navratil JS, Ahearn JM (2001) Apoptosis clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep 3:191–198PubMed Navratil JS, Ahearn JM (2001) Apoptosis clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep 3:191–198PubMed
14.
go back to reference Herrmann M, Zoller OM, Hagenhofer M, Voll R, Kalden JR (1996) What triggers anti-dsDNA antibodies? Mol Biol Rep 23:265–267PubMed Herrmann M, Zoller OM, Hagenhofer M, Voll R, Kalden JR (1996) What triggers anti-dsDNA antibodies? Mol Biol Rep 23:265–267PubMed
15.
go back to reference Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317CrossRefPubMed Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317CrossRefPubMed
16.
go back to reference Takahashi T, Tanaka M, Brannan C, et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976CrossRefPubMed Takahashi T, Tanaka M, Brannan C, et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976CrossRefPubMed
17.
go back to reference Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed
18.
go back to reference Bright J, Khar A (1994) Apoptosis: programmed cell death in health and disease. Biosci Rep 14:67–81PubMed Bright J, Khar A (1994) Apoptosis: programmed cell death in health and disease. Biosci Rep 14:67–81PubMed
19.
go back to reference Loo DT, Rillema JR (1998) Measurement of cell death. Methods Cell Biol 57:251–264PubMed Loo DT, Rillema JR (1998) Measurement of cell death. Methods Cell Biol 57:251–264PubMed
20.
go back to reference Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in SLE are clustered in two populations surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330CrossRefPubMed Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in SLE are clustered in two populations surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330CrossRefPubMed
21.
go back to reference Huggins ML, Todd I, Cavers MA, Pavuluri SR, Tighe PJ, Powell RJ (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322–328CrossRefPubMed Huggins ML, Todd I, Cavers MA, Pavuluri SR, Tighe PJ, Powell RJ (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322–328CrossRefPubMed
22.
go back to reference Licht R, Jacobs CW, Tax WJ, Berden JH (2001) No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice. Lupus 10:102–107CrossRefPubMed Licht R, Jacobs CW, Tax WJ, Berden JH (2001) No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice. Lupus 10:102–107CrossRefPubMed
Metadata
Title
Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus
Authors
Ou Jin
Ling-yun Sun
Kang-xin Zhou
Xin-su Zhang
Xue-bing Feng
Mo-yin Mok
Chak-sing Lau
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0972-x

Other articles of this Issue 2/2005

Clinical Rheumatology 2/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine